The Black Technology Era of Xueba

Wu Qiwen's flu has recovered, but he is still in the medical observation period. He cannot leave the laboratory yet. The life science laboratory will always check the level of NK cells in Wu Qiwen's body.

After the gene-expression-inducing drugs are stopped, it takes time for the number of high-level NK cells in the body to completely decline.

The laboratory needs to observe the effects of high levels of NK cells on human function and the immune system.

At the same time as the experiment, Gao Siqi's team also began to help write the experimental paper "Genetic induction of somatic differentiation of NK cells to kill Ebola virus".

Papers and experimental results will be submitted to WHO, and applications will be made for gene induction therapy in South Anfe or Congo-affected areas.

After several days of observation, Wu Qiwen's physical condition is normal, and the level of NK cells is gradually approaching the normal trend.

The laboratory also found an unexpected joy. Wu Qiwen's immune ability has been enhanced. The laboratory simply strikes while the iron is hot to carry out research on NK cells and human immune function.

Pangu Science and Technology Park, life science laboratory.

Gao Siqi gave Xiao Ming the paper she just wrote and said, "One step away."

Gao Siqi doesn't know if this is good news. "The control of gene expression in the life science laboratory is relatively proficient. We are only one step away from expressing human genes based on somatic cells."

Gao Siqi's words are rather convoluted. The more direct expression is to give me a somatic cell with complete human genes, and I can create any part of human beings, even human beings.

This is a major breakthrough in the life sciences, but a forbidden area for ethics, law and morals.

In fact, after the publication of the paper on gene expression regulation two years ago, there has been this debate in the academic world, and everyone can expect this day to come.

The research results of gene regulation and expression got a huge sensation in the academic world at the beginning. Many people in the industry have mentioned that this revolution in life science and technology has the possibility of impacting the Nobel Prize in biology.

It now appears that gene regulation of expression has achieved far more than that.

Xiao Ming set the red line for Gao Siqi's experiment, he said: "We can use this technology to create a liver, create a heart, create any organ or even limbs that can be used in the medical field,

But we cannot use it to create a person. "

Xiao Ming is well aware of the value of gene expression control to the whole human being, and even the whole biology.

This technology can express gene combination expression to the extreme without modifying the gene.

"I understand that this is currently a forbidden area in the field of human biology." Gao Siqi said: "But this technology will have wider uses. At present, we are working with medical centers to carry out totipotent expression experiments to see if it can help people with disabilities. ."

The experiment that Gao Siqi is doing is not only a breakthrough in life sciences, but also a major breakthrough in the medical field.

Xiao Ming is also concerned about the cost of NK gene-inducing preparations.

Gao Siqi replied: "The production method of NK gene inducers is also different from that of cancer cell gene inhibitor inducers. In the latter, because of different types of cancer, different gene sites and types, the methods of inhibitors and treatment methods are different. The cost is high. The former is only aimed at inducing NK cell populations, so it can be mass-produced, and in the future, as a drug preparation for the treatment of Ebola, influenza, HIV and even other viral infections, the cost can be controlled within a certain range.”

In the afternoon, Xiao Ming, experts from the Life Science Laboratory and Xiaochu jointly approved the paper, and then submitted it directly to the WHO Biomedical Research Institute in Yanjing, along with the application for on-site clinical trials in the epidemic area.

...

It is true that the people of Xia Guo had a wonderful Spring Festival, but the people of the Ebola-affected areas in West Africa and Southern Africa are suffering from the first short rainy season in 2022.

The short rainy season usually lasts from February to April. Compared with the long rainy season, the short rainy season has a shorter duration and less rainfall.

However, this year's climate is obviously abnormal, with the short rainy season rainfall exceeding that of the same period in previous years.

In the epidemic area, sewage, domestic garbage, patient excrement and other filth with viruses will flow into the tributaries near the village under the impact of sudden heavy rain. These tributaries will merge into the big river, flow downstream, and flow into more villages and living areas. , and even into cities.

The WHO headquarters in Africa has responded to the first-level defense mechanism and asked downstream villages to do a good job of virus defense.

But most parts of western and southern Africa are very backward, and most villagers still live a life of slash-and-burn farming, without running water or electricity. The water source is the river, and the food comes from nature.

This is very difficult for WHO's epidemic prevention and control, and after February, it has been found that foreign tourists traveled there to contract Ebola and died.

In response to such a situation, the WHO continued to negotiate hard with NL Gene Company of Maple Leaf Country. NL Gene Company resolutely refused to give in on the price, and the WHO did not have enough funds to control the local epidemic.

In fact, it is understandable for NL to do this. Why are the vaccines developed by others who have worked so hard and spent a lot of money for you to use at a low price?

And Africa is not Asia or Europe, where vaccines can be sold at low prices and take over the market. In Africa... Do villagers in African tribal villages use western medicine? Can you afford it?

All NL companies that speak with capital and interests feel that such investment will be in vain.

The WHO gave in again and urgently collected 300 million meters from major member states to prepare and purchase a batch of vaccines from NL company to deal with the epidemic in Africa.

The WHO paid a deposit of 30 million meters to NL and got the first batch of 300 vaccines.

It is a pity that the time has passed. The Ebola that is currently raging in West Africa and southern Africa is still a subspecies different from last year's Ebola.

Then NL's vaccine is ineffective against the subspecies virus.

WHO's 30 million wasted.

But this is not a big deal. NL company said that if they add 20% to the original price, they will remake the glycoprotein shell.

Isn't this a rip-off!

WHO:  …

Maple Leaf Country has decided on this business, and the global monopoly is the only one.

The spat between WHO and NL has also been reported internationally.

Netizens are divided into two factions.

One faction firmly supports the NL company, and thinks why the vaccine that it has spent a lot of money on research and development needs cheap assistance.

One faction firmly supports the WHO and believes that human beings should have universal values, and that no matter where or what country they are, their lives should be respected.

While the WHO was struggling, the WHO biomedical laboratory in Yanjing received the experimental papers and related applications of Pangu Technology.